| 0 (0%) | 07-08 19:59 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 1.65 |
1-year : | 1.79 |
| Resists | First : | 1.41 |
Second : | 1.53 |
| Pivot price | 1.39 |
|||
| Supports | First : | 1.21 |
Second : | 1 |
| MAs | MA(5) : | 1.4 |
MA(20) : | 1.36  |
| MA(100) : | 1.27 |
MA(250) : | 1.76 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 54.6 |
D(3) : | 62.3 |
| RSI | RSI(14): 45.5 |
|||
| 52-week | High : | 4.13 | Low : | 1.04 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ BBLG ] has closed above bottom band by 3.7%. Bollinger Bands are 24.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 1.35 - 1.36 | 1.36 - 1.36 |
| Low: | 1.24 - 1.25 | 1.25 - 1.26 |
| Close: | 1.3 - 1.31 | 1.31 - 1.32 |
Wed, 08 Jul 2026
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Wed, 08 Jul 2026
Why iOThree Shares Are Trading Higher By Around 70%; Here Are 20 Stocks Moving Premarket - Benzinga
Wed, 08 Jul 2026
What Put Bone Biologics (NASDAQ:BBLG) on Nasdaq Composite Radar? - Kalkine Media
Wed, 08 Jul 2026
Bone Biologics enters into definitive agreement for $3.0M private placement - MSN
Tue, 07 Jul 2026
Bone Biologics raises $3M now, with up to $6M more from warrants - Stock Titan
Tue, 07 Jul 2026
Bone Biologics Announces $3 Million Private Placement Financing with Potential Additional $6 Million from Warrants - Quiver Quantitative
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 2 (M) |
| Shares Float | 2 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0.2 (%) |
| Shares Short | 5 (K) |
| Shares Short P.Month | 3 (K) |
| EPS | -1.16 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 2.59 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -46.1 % |
| Return on Equity (ttm) | -75.5 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -3 (M) |
| Levered Free Cash Flow | -2 (M) |
| PE Ratio | -1.13 |
| PEG Ratio | 0 |
| Price to Book value | 0.5 |
| Price to Sales | 0 |
| Price to Cash Flow | -0.92 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|